In 2020, legal cannabis constituted a $12.8 billion global industry. During the forecast period stretching from 2022 to 2026, industry experts believe that the market will register an astounding compound annual growth rate (CAGR) of 27.25%.
Included in the report by Research and Markets is a segment covering the market’s overall size and forecast in five dominant currencies—USD, EUR GBP, JPY, and AUD. This currency exchange data is provided as a means of assisting industry leaders in making informed business-related decisions.
Global Legal Cannabis Market Divergence & Scope
Included in the research report is an overview of trends in various submarkets; close analysis of each submarket makes it easier for experts to predict forthcoming revenues.
Featured trends outlined in this report include the following:
Product: Flower, Oil, Hemp Oil, and Marijuana are the four main product trends.
Application: Adult-Use, B2B Avenues, and Medical were studied in-depth for the report, with the latter category being further segmented into Anxiety, Chronic Pain, Inflammation, and Sleep Disorders.
Region: A long list of locations were analyzed by researchers, including the Americas, Asia-Pacific, Europe, the Middle East, and Africa. The Americas is segmented into Argentina, Brazil, Canada, Mexico, and the United States. The United States is segmented into California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is segmented into Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East, and Africa is segmented into France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Repercussions of COVID-19 on the Global Legal Cannabis Market
Another interesting element of the global cannabis market report from Research and Markets is the information it pulls from the coronavirus (COVID-19) pandemic. The health emergency, which has impacted every country around the world, is expected to have long-term effects on the cannabis market throughout the forecast period.
Apply For Your Medical Marijuana Card Today
Veriheal has satisfied hundreds of thousands of patients nationwide
Get approved or your money back
Appointments available on-demand
Customer support available 24/7
COVID-19 has also posed major problems for other global supply chains, mainly due to the supply shockwave that erupted in China in February of 2020. Examples of some insights highlighted in this report include purchasing habits/behaviors, consumer demand, supply chain issues, governmental intervention, and fluctuations of current market forces.
Another element of the report assesses the global cannabis market’s competitive angle in regards to the different types of application, geographic appeal, and unique markets. This information will help vendors assess opportunities for future growth. Research and Markets outlines the best route(s) for vendors to succeed with merger and acquisition (M&A) techniques, research and development (R&D) strategies, investments and funding, partnerships, product launches, and geographical expansion.
Cannabis Company Profiles
The researchers from Research Future Markets name-dropped a handful of prominent market players in their report on the global cannabis market report, many of which are headquartered in North America.
The following global legal cannabis market pioneers are featured in the report:
ABcann Medicinals Inc
Aurora marijuana Inc.
Cannabis Sativa, Inc.
Cannabis Science, Inc.
Canopy Growth Corporation
Cronos Group Inc.
Green Organic Dutchman Holdings Ltd.
Green Thumb Industries
Harvest Health & Recreation Inc.
Maricann Group, Inc.
Medical Cannabis, Inc.
OrganiGram Holding Inc.
Terra Tech Corp.
Tikun Olam Ltd.
United Cannabis Corporation
VIVO Cannabis Inc.
VIVO marijuana Inc.
About Cannabis Research and Markets
Research and Markets was launched in Dublin, Ireland in the year 2002 with one simple aim–to provide industry insights and analysis for entrepreneurs who want to scale their business. More than 30,000 companies around the world depend on this provider’s reports for their market research efforts.
Since its inception a decade ago, the acclaimed firm has evolved into a global leader formarket research. The company prides itself on enticing globally-recognized clients (including more than 450 of the Fortune 500 Clients) with its high-quality statistical studies and interpretation covering 800+ industries.
To find out how you can get a complete copy of the global cannabis market report from Research and Markets, click here.
Suddenly, the world of magic mushrooms is almost as complicated as that of learning about cannabis. Shrooms or “magic” mushrooms have gained traction as a hallucinogenic therapeutic application for several different mental health circumstances such as depression and migraines—particularly when microdosing. It’s not just liberty caps anymore, folks. There are many different varieties and types…
As of now, 15 states have legalized adult use of med and rec, and when a state legalizes recreational use of cannabis, people tend to stop getting their mmj cards. But cannabis consumers who opt not to get a MMJ card are missing out on a bunch of benefits like paying lower costs, the ability…
Edibles are arguably one of the best means of recreational cannabis consumption—you get to eat a treat AND experience a long-lasting high. But it’s easy to end up dealing with some unwanted side effects due to the variability in the onset of these THC-packed goodies, which come in the form of brownies, cookies, gummies, chocolate,…
If you’re reading this, you are either a recreational cannabis veteran who has seen a handful of cannabis smokers passing out from puffing a joint and can’t seem to figure out why. Or, you are a newbie who wants to give recreational or medical cannabis a shot, and the burning question on your mind is,…
According to a new study published by the University of New Mexico (UNM) in the prestigious journal Frontiers in Pharmacology, researchers have unveiled a significant correlation between the sensation of “feeling high” and the relief of medical symptoms among cannabis patients. This landmark study probes uncharted territories, challenging pre-existing assumptions and opening new avenues for…
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.